Precigen, Inc. (PGEN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Precigen, Inc. on September 25, 2020. The report addresses a final settlement with the Securities and Exchange Commission (SEC) regarding an investigation into disclosures made in 2017 when the company operated as Intrexon Corporation. The investigation focused on the company's methane bioconversion platform.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The only specific financial figure disclosed is a civil money penalty of $2.5 million payable to the SEC as part of the settlement.
Material Changes
The primary material event is the resolution of the SEC investigation. The company consented to an administrative order without admitting or denying the allegations. The order requires the company to cease and desist from violating Section 13(a) of the Securities Exchange Act of 1934 and Rules 13a-11 and 12b-20.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or updated risk factors beyond the immediate legal resolution. The settlement represents a concluded contingency regarding the 2017 disclosures.
Key Facts for Investor Verification
- Settlement amount: $2.5 million civil penalty paid to the SEC.
- Subject of investigation: 2017 disclosures regarding the methane bioconversion platform under the former name Intrexon Corporation.
- Legal stance: Company consented to the order without admitting or denying the allegations.
- Compliance requirement: Company must cease and desist from future violations of specified reporting rules.